Mark .w. S
SVP, Chief Commercial Officer
Amarin Cooparation
Ireland
Biography
Mr. Salyer joined Amarin in September 2017 with extensive experience in sales and marketing for global pharmaceutical companies. Mr. Salyer has grown start-up business units to over $1B in yearly revenue, including Teva’s respiratory products unit. Prior to Teva, Mr. Salyer led U.S. commercial operations and the global respiratory marketing group at Altana Pharma AG. Mr. Salyer also worked at GlaxoSmithKline for 17 years, where he held a variety of jobs with increasing responsibility culminating in his last position of VP, global commercial strategy for the respiratory division.
Research Interest
commercialization and development of therapeutics to improve cardiovascular health. Amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids
